Target intelligence / Profile preview

NMD3 ribosome export adaptor pseudogene 1 (NMD3P1)

Target
NMD3P1
Molecular classification
Other (pseudogene)
01

Overview

NMD3 ribosome export adaptor pseudogene 1 (NMD3P1) is classified as a pseudogene related to the NMD3 ribosome export adaptor gene. While NMD3 encodes a critical adaptor protein for CRM1-mediated nuclear export of the 60S ribosomal subunit and is involved in ribosome biogenesis and cellular homeostasis[2][3][5][6], NMD3P1 itself does not code for a functional protein and has no known biological function, therapeutic relevance, disease association, or biomarker potential. Its existence is identified mainly via its sequence similarity to NMD3, but it is not recognized as a drug target nor is it implicated in any established cellular processes or pathologies[1][2]. Clarifications: - The query refers to a pseudogene ("NMD3P1"), not the functional human gene "NMD3 ribosome export adaptor," which is a well-characterized ribosome biogenesis factor and sometimes (incorrectly) confused in database or search outputs[1][2]. - Pseudogenes do NOT encode functional or druggable proteins and are NOT considered therapeutic targets. - If structured data or downstream annotation pipelines require a canonical target, only the parental NMD3 gene/protein is suitable. This entry should be flagged as a non-functional, non-target entity. Summary of issues: - NMD3P1 is NOT a therapeutic target. - Entry is likely included in search outputs for completeness or due to sequence similarity, but does not meet criteria for further analysis as a druggable molecule.

02

Biological functions

None (pseudogene)
03

Disease associations

None established for this pseudogene

Beyond the preview

Go deeper on NMD3 ribosome export adaptor pseudogene 1 (NMD3P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NMD3 ribosome export adaptor pseudogene 1 (NMD3P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call